News
MRK
106.06
-0.53%
-0.56
BMY vs AMGN: Which Biotech Stock Is More Resilient Now?
NASDAQ · 16h ago
Merck: A Post-2028 Slowdown Doesn't Kill The Long-Term Thesis
Seeking Alpha · 17h ago
iShares S&P 500 Value ETF Experiences Big Outflow
NASDAQ · 18h ago
3 Dividend-Paying Pharma Stocks Worth Watching for Steady 2026 Gains
NASDAQ · 21h ago
Dow Movers: NVDA, MRK
NASDAQ · 1d ago
My Market Outlook For 2026: Focus On Pharma For Consistent Returns, Potential Skyrocketing Shares
Seeking Alpha · 1d ago
2026 S&P 500 Outlook: Look For Pharma Sector To Lead The Way With Potential Changes
Seeking Alpha · 1d ago
Cidara: Merck's Acquisition Based On CD388 Flu Prevention Potential
Seeking Alpha · 1d ago
Weekly Report: what happened at MRK last week (1222-1226)?
Weekly Report · 2d ago
SCHD: Coming Redemption Year; 2026 Could Favor Dividend Discipline
Seeking Alpha · 2d ago
Notable healthcare headlines for the week: J&J, Pfizer, and Novo Nordisk in focus
Seeking Alpha · 2d ago
3 Drug Stocks to Buy at a Discount
The Motley Fool · 3d ago
enGene Holdings: A Potential Oncology Entrant
Seeking Alpha · 4d ago
Looking Into Merck & Co Inc's Recent Short Interest
Benzinga · 4d ago
Can J&J's Pipeline Progress in 2025 Aid Long-Term Growth?
NASDAQ · 4d ago
3 Best ETFs to Invest In, According to AI Analyst, 12/26/2025
TipRanks · 4d ago
Why Merck (MRK) Outpaced the Stock Market Today
NASDAQ · 6d ago
PFE's Oncology & Obesity Pipeline Position It for Post-LOE Growth
NASDAQ · 6d ago
Dow Movers: NVDA, NKE
NASDAQ · 6d ago
Amgen Strikes Drug Pricing Deal With Trump: What Investors Should Know
NASDAQ · 6d ago
More
Webull provides a variety of real-time MRK stock news. You can receive the latest news about Merck & Co through multiple platforms. This information may help you make smarter investment decisions.
About MRK
Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. It sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.